|
GB1578323A
(en)
*
|
1976-02-26 |
1980-11-05 |
Rustenburg Platinum Mines Ltd |
Compositions containing platinum
|
|
GB1585103A
(en)
*
|
1976-04-06 |
1981-02-25 |
Rustenburg Platinum Mines Ltd |
Pharmaceutical compositions containing platinum compounds
|
|
US4255417A
(en)
*
|
1976-08-04 |
1981-03-10 |
Johnson Matthey, Inc. |
Platinum compounds for the irradication of skin blemishes
|
|
US4115418A
(en)
*
|
1976-09-02 |
1978-09-19 |
Government Of The United States Of America |
1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
|
|
JPS6041077B2
(ja)
*
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4175133A
(en)
*
|
1977-02-18 |
1979-11-20 |
United States Of America |
1,2-Diaminocyclohexane platinum (II) complexes having antineoplastic activity against L1210 leukemia
|
|
US4278660A
(en)
*
|
1977-05-02 |
1981-07-14 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
|
US4151185A
(en)
*
|
1977-05-02 |
1979-04-24 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
|
US4137248A
(en)
*
|
1977-08-29 |
1979-01-30 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
|
|
SE447385B
(sv)
*
|
1977-10-19 |
1986-11-10 |
Johnson Matthey Co Ltd |
Cis-koordinationsforeningar av platina
|
|
US4225529A
(en)
*
|
1977-10-19 |
1980-09-30 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
|
US4203912A
(en)
*
|
1977-10-19 |
1980-05-20 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
|
NL7807334A
(nl)
*
|
1978-07-06 |
1980-01-08 |
Tno |
Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
|
|
JPS5554852A
(en)
*
|
1978-10-16 |
1980-04-22 |
Tsuneji Yamamoto |
Raw sea urchin eggs and method of treating them
|
|
JPS55130992A
(en)
*
|
1979-03-31 |
1980-10-11 |
Yoshinori Kitani |
Novel platinum complex
|
|
NL8101026A
(nl)
*
|
1981-03-03 |
1982-10-01 |
Tno |
Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel.
|
|
JPS5896024A
(ja)
*
|
1981-10-16 |
1983-06-07 |
リチヤ−ド・エフ・ストツケル |
白金毒解毒剤
|
|
US4578491A
(en)
*
|
1982-06-28 |
1986-03-25 |
Engelhard Corporation |
Bis(thiocyanato)palladium(II) complexes
|
|
IT1153974B
(it)
*
|
1982-09-23 |
1987-01-21 |
Erba Farmitalia |
Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
|
|
US4560782A
(en)
*
|
1982-11-19 |
1985-12-24 |
Research Corporation |
Anti-tumor diplatinum coordination compounds
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
US4617189A
(en)
*
|
1983-04-14 |
1986-10-14 |
Stockel Richard F |
Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
|
|
EP0210291A1
(en)
*
|
1985-07-27 |
1987-02-04 |
American Cyanamid Company |
Platinum complexes of antitumor agents
|
|
US4544759A
(en)
*
|
1983-07-29 |
1985-10-01 |
American Cyanamid Company |
Platinum complexes of antitumor agents
|
|
GB8328218D0
(en)
*
|
1983-10-21 |
1983-11-23 |
Johnson Matthey Plc |
Oral compositions
|
|
HU193809B
(en)
*
|
1984-09-12 |
1987-12-28 |
Chugai Pharmaceutical Co Ltd |
Process for producing new platinum complexes
|
|
US4588831A
(en)
*
|
1984-11-09 |
1986-05-13 |
Natec |
Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
|
|
ATE86967T1
(de)
*
|
1988-01-09 |
1993-04-15 |
Asta Medica Ag |
1,2-bis(aminomethyl)cyclobutan-platin-komplexe.
|
|
GB9502799D0
(en)
|
1995-02-14 |
1995-04-05 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US8173686B2
(en)
|
2006-11-06 |
2012-05-08 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
|
JP2010533714A
(ja)
*
|
2007-07-16 |
2010-10-28 |
ポニアード ファーマシューティカルズ， インコーポレイテッド |
ピコプラチンのための経口製剤
|
|
CA2715329A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Picoplatin and amrubicin to treat lung cancer
|
|
ES2609931T3
(es)
|
2010-06-18 |
2017-04-25 |
Myriad Genetics, Inc. |
Métodos y materiales para evaluar la pérdida de heterocigosidad
|
|
EP3109325B1
(en)
|
2010-08-24 |
2018-12-26 |
Dana-Farber Cancer Institute, Inc. |
Methods for predicting anti-cancer response
|
|
CA2839210A1
(en)
|
2011-06-17 |
2012-12-20 |
Myriad Genetics, Inc. |
Methods and materials for assessing allelic imbalance
|
|
ES2759533T5
(es)
|
2011-12-21 |
2023-06-22 |
Myriad Genetics Inc |
Métodos y materiales para evaluar la pérdida de heterocigosidad
|
|
ES2997859T3
(en)
|
2012-02-23 |
2025-02-18 |
Childrens Medical Center |
Methods for predicting response to parp inhibitors
|
|
US11091808B2
(en)
|
2012-06-07 |
2021-08-17 |
Institut Curie |
Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
|
|
WO2014160080A1
(en)
|
2013-03-14 |
2014-10-02 |
Children's Medical Center Corporation |
Cancer diagnosis, treatment selection and treatment
|
|
DK2981624T3
(da)
|
2013-04-05 |
2020-03-02 |
Myriad Genetics Inc |
Fremgangsmåder til vurdering af homolog rekombinationsdeficiens og forudsigelse af respons på cancerbehandling
|
|
EP3080292B1
(en)
|
2013-12-09 |
2022-02-02 |
Institut Curie |
Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
|
|
ES2946251T3
(es)
|
2014-08-15 |
2023-07-14 |
Myriad Genetics Inc |
Métodos y materiales para evaluar la deficiencia de recombinación homóloga
|
|
EP4141127B1
(en)
|
2021-08-30 |
2024-10-09 |
Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln |
Method for assessing homologous recombination deficiency in ovarian cancer cells
|